• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

THERAPEUTIC STRATEGY OF RHEUMATOID ARTHRITIS BY THE REGULATION OF ANTI-ONCOGENE p53 AND AN ANTI-ANGIOGENIC FACTOR.

Research Project

Project/Area Number 11670460
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field 内科学一般
Research InstitutionTOKYO WOMEN'S MEDICAL UNIVERSITY

Principal Investigator

YAMANAKA Hisashi  TOKYO WOMEN'S MEDICAL UNIVERSITY, ASSOCIATE PROFESSOR, 医学部, 助教授 (10166754)

Co-Investigator(Kenkyū-buntansha) NAKAJIMA Hiroshi  TOKYO WOMEN'S MEDICAL UNIVERSITY, ASSISTANT, 医学部, 助手 (40266838)
SENDO Wako  TOKYO WOMEN'S MEDICAL UNIVERSITY, ASSISTANT, 医学部, 助手 (40277140)
TAIGUCHI Atsuo  TOKYO WOMEN'S MEDICAL UNIVERSITY, ASSISTANT PROFESSOR, 医学部, 講師 (40179833)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥2,800,000 (Direct Cost: ¥2,800,000)
Fiscal Year 2000: ¥1,400,000 (Direct Cost: ¥1,400,000)
Fiscal Year 1999: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsRHEUMATOID ARTHRITIS / ANGIOGENESIS / SYNOVITIS / THROMBOSPONDIN-1 / COLLAGEN-INDUCED ARTHRITIS / TSP-1
Research Abstract

Angiogenesis is a characteristic feature in the synovitis in patients with early rheumatoid arthritis (RA), and also is believed to have a crucial role in the proliferation of rheumatoid synovium. Angiogenesis is balanced between the pro-angiogenic factors and anti-angiogenic factors. To elucidate the pathogenesis of angiogenesis in rheumatoid arthritis, we investigated the expression of pro-angiogenic factors including vascular endothelial growth factor (VEGF) and anti-angiogenjc factor, thrombospondin-1 (TSP-1). And we showed that the expression of TSP-1 is suppressed in synovial tissue with active inflammation, and this lead to an imbalance of pro-angiogenic factors and anti-angiogenic factors. From this notion, the regulation of factors involved in the angiogenesis is a candidate of molecular target in RA therapy, especially in patients with early RA.Thus, we investigated the introduction of TSP-1 gene in the experimental arthritis model mouse. In the preventive experiments, pre-introduction of TSP-1 plasmid into mouse with collagen-induced arthritis significantly delayed the onset of arthritis. Also, introduction of TSP-1 plasmid into the mouse who have already have collagen-induced arthritis suppressed the extent of arthritis. These results showed the suppression of angiogenesis by the over-expression of TSP-1 successfully inhibit the progression of synovitis. These investigations clearly showed the potential of TSP-1 introduction as a new strategy in RA treatment.

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi